Information for Lantus (insulin glargine)
Lantus is a long-acting modified version of human insulin (insulin analog) used to control blood sugar in patients with Type 1 and Type 2 diabetes.
To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.
Related Information
- FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
- FDA Drug Safety Podcast: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer
- Early Communication About Safety of Lantus (insulin glargine)